Global Markets Direct's, 'Prosensa Therapeutics B.V. - Product Pipeline Review - 2014', provides an overview of the Prosensa Therapeutics B.V.'s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Prosensa Therapeutics B.V.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Full Report Details at
- http://www.fastmr.com/prod/900854_prosensa_therapeutics_bv_product_pipeline_review.aspx?afid=101
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
* The report provides brief overview of Prosensa Therapeutics B.V. including business description, key information and facts, and its locations and subsidiaries
* The report reviews current pipeline of Prosensa Therapeutics B.V.'s human therapeutic division and enlists all their major and minor projects
* The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
* Special feature on out-licensed and partnered product portfolio
* The report summarizes all the dormant and discontinued pipeline projects
* Latest company statement
* Latest news and deals relating to the Prosensa Therapeutics B.V.'s pipeline products
Reasons to Get this Report
* Evaluate Prosensa Therapeutics B.V.'s strategic position with total access to detailed information on its product pipeline
* Assess the growth potential of Prosensa Therapeutics B.V. in its therapy areas of focus
* Identify new drug targets and therapeutic classes in the Prosensa Therapeutics B.V.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
* Develop strategic initiatives by understanding the focus areas of Prosensa Therapeutics B.V. and exploit collaboration and partnership opportunities
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Plan mergers and acquisitions effectively by identifying the most promising pipeline of Prosensa Therapeutics B.V.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Explore the dormant and discontinued projects of Prosensa Therapeutics B.V. and identify potential opportunities in those areas
* Avoid Intellectual Property Rights related issues
Partial Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
Prosensa Therapeutics B.V. Snapshot
Prosensa Therapeutics B.V. Overview
Key Information
Key Facts
Prosensa Therapeutics B.V. - Research and Development Overview
Key Therapeutic Areas
Prosensa Therapeutics B.V. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Prosensa Therapeutics B.V. - Pipeline Products Glance
Prosensa Therapeutics B.V. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Prosensa Therapeutics B.V. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Prosensa Therapeutics B.V. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Prosensa Therapeutics B.V. - Drug Profiles
drisapersen
Product Description
Mechanism of Action
R&D Progress
PRO-045
Product Description
Mechanism of Action
R&D Progress
PRO-044
Product Description
Mechanism of Action
R&D Progress
PRO-053
Product Description
Mechanism of Action
R&D Progress
PRO-052
Product Description
Mechanism of Action
R&D Progress
PRO-055
Product Description
Mechanism of Action
R&D Progress
PRO-135
Product Description
Mechanism of Action
R&D Progress
PRO-289
Product Description
Mechanism of Action
R&D Progress
PROSPECT
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide for Bone Diseases
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide for Cancer
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide for Immune Disorders
Product Description
Mechanism of Action
R&D Progress
RNAi Oligonucleotide for Skin Diseases
Product Description
Mechanism of Action
R&D Progress
Prosensa Therapeutics B.V. - Pipeline Analysis
Prosensa Therapeutics B.V. - Pipeline Products by Target
Prosensa Therapeutics B.V. - Pipeline Products by Route of Administration
Prosensa Therapeutics B.V. - Pipeline Products by Molecule Type
Full Table of Contents is available at:
-- http://www.fastmr.com/prod/900854_prosensa_therapeutics_bv_product_pipeline_review.aspx?dt=t&afid=101
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
read full article